129 results
Page 4 of 7
6-K
EX-99.1
1nj6ufghjythq8 7t
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.2
ygactw rv9wkiuu0qi
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
q61 tzuojw
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
2gp812p 9qvt
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
aw6pcs5jur8
25 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
bxa3hc25v81rz9b
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
49qxx3lgd8 11o3k5w
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
uwxnd
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
7d17i4ugrhu zsw4gv
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
CORRESP
nwjf1wr
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
ljh3g4e
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
qd3zk8doz2i3x 3f0ko
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.2
74t48t 42x5fxo4q9hwm
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
o007h4hj8r
29 Oct 14
RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial
12:00am
6-K
EX-99.1
t2pf4
3 Sep 14
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
12:00am